Herborium Group Inc (HBRM)

[rodd21]

Could someone please explain the strategy going on here. I've been watching level 2 and it is clear that via low (usu. below market value) asks that the share price is intentionally being driven down. Is this because not all of the shares granted to company at the beginning of year, the 90 million that weren't all put out on the market are being issued at intervals when the price is at .001 since that was the par price? And what does that mean for the company and future share price (obviously if that is the case the share price is being diluted). But what is the end game here? I'm a grad student in the medical sciences who has used my molecular biology background to make biotech trades for some extra income and I understand some (the more I learn the more I realize I don't know) of how the market works and is often manipulated. But the concept behind being somewhere in-between an herbal company with no clinical trials and a full fledged biotech going through fda approval process is solid (HBRM doing clinical trials on products just not seeking fda approval). Seemed worth some speculation. And the company seems to be doing well with success of products and sales. If someone could PM me or public reply more about these (this one especially) and otc penny stocks and what is going on here I would really appreciate it. I could really use some guidance and more info.
Thanks